Cite
HARVARD Citation
Quagliariello, V. et al. (n.d.). Cardioprotective effects of PCSK9 inhibitor evolocumab against doxorubicin-trastuzumab sequential treatments and ipilimumab-induced cardiotoxicity: the role of MyD88/NF-KB/mTORC1 pathways. European heart journal. p. . [Online].